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Background. Evaluating whether an infectious disease has reached a turning point is important for planning additional inter-
vention efforts. This study aimed to analyze the changing patterns and the tempogeographic features of the coronavirus disease 2019 
(COVID-19) epidemic in China, to provide further evidence for real-time responses.
Methods. Daily data on COVID-19 cases between 31 December 2019 and 26 February 2020 were collected and analyzed for 
Hubei and non-Hubei regions in China. Observed trends for new and cumulative cases were analyzed through joinpoint regression 
analysis. Spatial analysis was applied to show the geographic distribution and changing patterns of the epidemic.
Results. By 26 February 2020, 78 630 confirmed COVID-19 cases had been reported in China. In Hubei, an increasing trend 
(slope = 221) was observed for new cases between 24 January and 7 February 2020, after which a decline commenced (slope = −868). 
However, as the diagnosis criteria changed, a sudden increase (slope = 5530) was observed on 12 February, which sharply decreased 
afterward (slope = −4898). In non-Hubei regions, the number of new cases increased from 20 January to 3 February and started to 
decline afterward (slope = −53). The spatial analysis identified Chongqing, Guangzhou, Shenzhen, Changsha, Nanchang, Wenzhou, 
Shanghai, Xinyang, Jining, and Beijing as the hotspots outside of Hubei Province in China.
Conclusions. The joinpoint regression analysis indicated that the epidemic might be under control in China, especially for re-
gions outside of Hubei Province. Further improvement in the response strategies based on these new patterns is needed.
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In December 2019, a new coronavirus disease (COVID-
19) emerged in Wuhan City located in central China’s Hubei 
Province, infecting 81 548 people (78 630 cases are in China 
and 2918 in 37 other countries) by 26 February 2020 and 
leading to the death of 2747 people in China [1, 2]. The high 
transmission rate (R0 = 2.2 [range, 1.4–3].9) and long incuba-
tion period (average, 6.4 days [range, 2.1–11.1 days) of the virus 
coupled with its relatively high mortality rate (2%) made it a 
global public health emergency event [3–6]. The situation is 
further compounded by the high number of presumed hospital-
acquired infections and the potential for secondary transmis-
sion through asymptomatic contacts [4–8].
In response to this epidemic, China issued rapid and com-
prehensive public health emergency interventions at the na-
tional level; upgraded quarantine and isolation guidelines; and 
expanded its Level 1 Public Health Emergency Response to 
31 provinces within mainland China. All provinces issued the 
highest level of emergency public health alerts and responses 
within the national public health management system, and cities 
with high numbers of reported cases went under lockdown with 
restricted access in most of their communities as part of preven-
tive measures. Due to the high probability of the virus causing a 
global pandemic, the World Health Organization (WHO) on 30 
January 2020 declared the COVID-19 outbreak a Public Health 
Emergency of International Concern [9].
The Chinese government continued to act and implement 
containment and preventive measures in the global public best 
interest by reporting the epidemic and improving transparency 
in data reporting. The ever-increasing flow of information freely 
available and easily accessible online has allowed the public 
to understand the emerging epidemic status and the need for 
compliance. The data have also provided a great opportunity 
for researchers and public authorities to better understand the 
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epidemic trends, predict the disease patterns, and provide tech-
nical support through data analysis. Moreover, the data pro-
vided a better understanding of how severe acute respiratory 
syndrome coronavirus (SARS-CoV-2) spread temporally and 
geographically.
This study aimed to assess the turning point (which in this 
study was defined as the time when the rate of case accumula-
tion changed from increasing to decreasing or vice versa) of the 
epidemic. The study also aimed to identify the tempogeographic 
patterns of the epidemic at the city, provincial, and national 
levels and to analyze the changing patterns of the infection.
METHODS
Data Collection and Processing
Multiple publicly available data were collected for this data anal-
ysis. Daily data on COVID-19 in China were derived from the 
national and provincial health commissions’ websites (http://
www.nhc.gov.cn/) [1]. To reflect the entire process of the out-
break, the data were systematically collected from 31 December 
2019, when the Hubei health commission first reported about 
an unknown pneumonia, till 26 February 2020. The meas-
ures collected from these sources included the report date; the 
number of new cases reported per day; the cumulative number 
of cases per day; and the cumulative number of deaths per day 
at the city, provincial, and national levels. Where only cumula-
tive cases were reported by dates, the daily reported number of 
new cases was estimated by computing the difference between 
cumulative reported cases in the new day and the previous day. 
The number suspected cases in Hubei were collected from 8 
February 2020 to 26 February 2020. The number of cumulative 
cases and deaths outside  of China on 26 February 2020 were 
obtained from the WHO’s situation reports [2]. The spatial data 
on China were from GADM version 3.6 [10]. All of these data 
sources are freely accessible to the public.
Data Analysis
All the statistical analyses were conducted using RStudio soft-
ware (R Core Team, 2016) and Joinpoint Trend Analysis version 
4.7.0.0 software (US National Cancer Institute). The maps and 
spatial analysis were generated using ArcGIS 10.2 software (Esri 
Inc, Redlands, California). Mortality rate was defined as the 
proportion of deaths in confirmed cases during the study pe-
riod and was calculated and compared by region (Hubei, China; 
non-Hubei, China; overall in China; and the rest of the world).
Because Hubei Province, as the center of the COVID-19 out-
break, had more reported cases, we hypothesized that its di-
sease trend might differ from non-Hubei regions. Therefore, 
joinpoint regression was applied to analyze the trends of new 
and cumulative cases for Hubei and non-Hubei regions and to 
obtain the dates of the outbreak changing points. Trend anal-
ysis of suspected cases was calculated for Hubei Province as the 
disease diagnosis criteria was changed on 12 February for the 
region and multiple joinpoints were used to reflect the infection 
in stages to showcase the changing epidemic patterns.
Dynamic maps of new and cumulative cases for Hubei 
Province were created by grouping the number of COVID-19 
cases into 8 classes based on natural breaks to help visualize the 
distribution change by city. Spatial autocorrelation analysis and 
hotspot analysis were applied to examine the presence of epi-
demic clusters and detect non-Hubei areas that are at high risk. 
Tibet, which had recorded only 1 COVID-19 case, was excluded 
from the spatial analysis. Clustering of COVID-19 was con-
sidered present if the Moran I index was > 0 and P was < .05 in 
the spatial autocorrelation analysis. In the hotspot analysis, the 
conceptualization of spatial relationship was set to inverse dis-
tance with the hypothesis that areas with smaller distance have 
a higher impact on the calculated field. The z score, P value, 
and Gi_Bin were calculated in the hotspot analysis. High z 
score with P values < .01, <.05, and <.1 indicated a hotspot. The 
area where Gi_Bin = 3 was the hotspot with 99% confidence; 
Gi_Bin = 2 was hotspot with 95% confidence; Gi_Bin = 1 was 
hotspot with 90% confidence; and Gi_Bin = 0 was classified as 
not significant.
RESULTS
By 26 February, a total of 78 630 COVID-19 cases had been re-
ported in China and 2918 in 37 other countries.
Changing Trend of the Epidemic
The joinpoint regression in this study was separated into 2 
parts: (1) cases found in Hubei Province and (2) cases outside 
Hubei Province in China (Figure 1A–D).
The joinpoint regression for daily reported new cases showed 
2 trends for new cases found in Hubei Province and non- Hubei 
regions in China (Figure 1A and 1B). The overall trend for new 
cases in Hubei Province increased very slowly at the beginning 
of the outbreak until 24 January 2020 (slope = 5) and started a 
fast increase until the first peak was reached around 7 February 
(slope = 221), after which it started to decrease (slope = −868). 
However, a sudden peak in the trend was observed with 14 840 
new cases on 12 February 2020, as the disease diagnosis criteria 
were changed (from laboratory-based confirmation to clinical 
diagnosis; Figure 1A) for Hubei Province. The number then re-
turned to 2420 on 14 February and continued to decrease to 
409 on 26 February 2020 (slope = 143). Regions outside Hubei 
Province observed a different disease pattern as the trend for 
daily reported new cases rapidly increased after the new cases 
were reported on 20 January 2020 for the first time (slopes = 82). 
The increase of new cases became relatively slow after 29 January 
(slope = 24) and reached a peak on 3 February 2020. The 
number of newly reported cases in the regions quickly declined 
after the peak (slope = −53; see Figure 1B) and was < 100 in most 
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days after 16 February 2020, when the decreasing trend of new 
cases became gentle (slope = −9). The cumulative cases showed 
increasing but different trends for both Hubei Province and 
non-Hubei provinces in China. The trend for Hubei Province 
stayed relatively stable from 31 December 2019 to 25 January 
2020, with a slope of 30 (Figure 1C), and the number of cumu-
lative cases kept accelerating in the next 3 stages (slope = 1005 
in stage 2, slope = 2572 in stage 3, and slope = 9315 in stage 
4) until 13 February 2020 (slope = 1547). The increase further 
slowed after 19 February 2020 (slope = 402). The trend for the 
cumulative cases outside Hubei Province in China behaved 
similarly in growth (trend slope increased from 200 in stage 1 to 
729 in stage 2) to but more gentle than that of Hubei Province in 
stages 2 and 3 (Figure 1D); however, it changed at the third stage 
as the increasing trend of cumulative cases started to decelerate 
after 7 February 2020 (slope = 363), which was about 1 week 
before the trend in Hubei started to slow down; the increase of 
cumulative cases was gentle after 14 February 2020 (slope = 67).
Suspected cases for Hubei showed a rapid decreasing trend from 
8 February 2020, and the decrease slowed down after 13 February 
2020 (Figure 2). The number of new cases also decreased in general 
after 9 February 2020, except on 12 February 2020, when the new 
cases rapidly increased and suspected cases largely decreased. The 
decreasing trends of both new and suspected cases in Hubei imply 
that the disease outbreak may be controlled gradually. However, as 
the number of new cases and suspected cases were still above 400 and 
2000 on 26 February 2020, respectively, more efforts are needed to fur-
ther reduce COVID-19 infection.
Disease Mortality
The mortality rate for COVID-19 in Hubei Province, non-
Hubei regions in China, overall China, and regions outside of 
China were 4.0%, 0.8%, 3.5%, and 1.5%, respectively (Table 1). 
It is noteworthy that the mortality rate in non-Hubei regions in 
China and outside of China was much cumulatively lower than 
that in Hubei and that China’s national mortality rate was highly 
impacted by Hubei’s (Supplementary Materials 1).
Spatial Pattern of COVID-19 Outbreak
Dynamic maps of Hubei were produced to show the new 
cases and cumulative cases changing patterns over time 
(Supplementary Materials 2 and 3). Huanggang, a neighboring 
city of Wuhan that recorded 12 cases on 20 January 2020, was 
the first city to record a case outside Wuhan. All other cities 
Figure 1. Joinpoint regression analysis for coronavirus disease 2019 cases reported in China between 31 December 2019 and 26 February 2020. A, Number of new cases 
found in Hubei varies with date elapsed from 31 December 2019. B, Number of new cases found in non-Hubei region of China varies with date elapsed from 20 January 2020. 
C, Number of cumulative cases found in Hubei varies with date elapsed from 31 December 2019. D, Number of cumulative cases found in non-Hubei region of China varies 
with date elapsed from 20 January 2020. *Slope is significantly different from zero at α = .05 level. Dates are presented as month/day/year.
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started to report new cases from 21 to 27 January 2020, and 
new cases reported in Wuhan rapidly increased after 26 January 
2020, followed by Huanggang, Xiaogan, and other nearby cities. 
However, Qianjiang, Tianmen, and Xiantao, which are also near 
Wuhan, were not affected as severely as the other neighboring 
cities. The number of new cases in each city was < 42 from 20 
February, except for Wuhan; furthermore, > 4 cities reported 
zero new cases every day since 22 February 2020. Joinpoint 
analysis identified the changing points for cumulative cases 
in the non-Hubei region to be 26 January, 7 February, and 14 
February, and these data in addition to 26 February were used 
to develop a series of distribution maps to showcase the devel-
opment of the disease outbreak. A  few areas near Hubei and 
in east China reported COVID-19 cases in stage A (26 January 
2020; Figure 3A) and later evolved into stage B (7 February 
2020; Figure 3B) by spreading to most of east China. In stage 
B, the disease spread throughout the country but with < 20 
cases in many cities except for parts of northwest China that 
were unaffected. More cases were found in areas near Hubei, 
especially Chongqing, where 426 people were infected. Some 
distant cities from Hubei, such as Guangzhou, Shenzhen, 
Wenzhou, Shanghai, and Beijing, were also highly affected with 
> 160 cases in each city, especially Wenzhou, where 438 people 
were infected. The number of cumulative cases in the areas near 
Hubei and highly affected cities gradually and slightly increased 
when the outbreak evolved into stage C (14 February 2020) and 
Stage D (26 February 2020), and all unaffected areas except 
Yichun in Heilongjiang Province remained safe (Figure 3C and 
3D). This evidence indicated that although the disease rapidly 
spread at the beginning, preventive control was achieved.
In spatial autocorrelation analysis for non-Hubei re-
gions (Tibet excluded), the Moran I  index was 0.13 (P < .01), 
demonstrating that the epidemic clusters of COVID-19 were 
present. The hotspot analysis (Figure 4) indicated Chongqing, 
Guangzhou, Shenzhen, Changsha, Nanchang, Wenzhou, 
Shanghai, Xinyang, Jining, and Beijing to be epidemic hotspots 
with about 99% confidence, meaning that these cities were at 
high risk during the disease outbreak. Harbin was the hotspot 
with 95% confidence and at relatively high risk. Hangzhou, 
Hefei, Yueyang, Zhengzhou, Ningbo, Bengbu, Fuyang, and 
Nanyang were also hotspots with 90% confidence and moderate 
risk of the disease.
DISCUSSION
Knowing the epidemic patterns of an infectious disease is im-
portant in the planning of public health responses. As the spread 
of COVID-19 trigged the highest level of global emerging re-
sponse, especially in China, understanding the real-time pat-
terns of the epidemic would be useful for guiding further 
time-sensitive responses. This study extended the existing lit-
erature by conducting assessment of the changing patterns of 
the epidemic, detecting the turning points of the outbreak, and 
analyzing the tempogeographic pattern of the infection.
Our findings indicated that a turning point of the epidemic may 
have been reached in both Hubei and non-Hubei regions in China, 
as evidenced by the overall decreasing trend of newly confirmed 
cases both in and outside Hubei Province. In Hubei Province, 
there was a sudden increase of the number of newly identified 
cases, which delayed the reaching of a turning point. However, the 
sudden increase in the number of confirmed cases was mainly due 
to a change in the diagnosis criteria of COVID-19 for the prov-
ince (changed from laboratory-confirmed cases only laboratory-
confirmed plus  to clinically diagnosed cases since 12 February 
Figure 2. Joinpoint regression analysis for coronavirus disease 2019 cases re-
ported in China between 8 February and 26 February 2020. *Slope is significantly 
different from zero at α = .05 level. Dates are presented as month/day/year.
Table 1. Mortality Rate of Coronavirus Disease 2019 (COVID-19) in Hubei 
Province, China, and Other Countries, by 26 February 2020
Region Confirmed Cases Mortality Mortality Rate
Hubei Provincea 65 596 2641 4.0%
Non-Hubei regions in China  
(including Hong Kong,  
Macau, and Taiwan)a
13 034 106 0.8%
Overall in China 78 630 2747 3.5%
Outside of Chinab 2918 44 1.5%
aData collected from the COVID-19 daily report of the National Health Commission of the 
People’s Republic of China.
bData collected from the COVID-19 situation report of the World Health Organization.
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2020) [11] to facilitate early treatment and care for suspected cases 
and to prevent secondary transmission. Without the observed 
sudden spike on 12 February 2020, the turning point may have 
been reached on 8 February. Nevertheless, all of these indicators 
suggest that the epidemic in China has been turning for the better 
since 14 February 2020.
However, reaching a turning point for an epidemic does not 
necessarily signify the end of the epidemic as secondary transmis-
sion of SARS-CoV-2 continues in China and worldwide. Thus, 
the need for improved efforts to reduce the timeline from case 
identification to confirmation still remains urgent. Also, efforts 
to strengthen quarantine and isolation procedures in areas with 
a serious epidemic are continually required. Differentiated pre-
vention efforts should be implemented depending on a region’s 
epidemic level. For example, areas with relatively low numbers of 
or no SARS-CoV-2–infected cases should implement strategies 
aimed at reducing the impact of the epidemic on the economy and 
encouraging people to resume normal daily life activities. Future 
studies should aim to evaluate the impact of the de-quarantine 
and de-isolation strategies in these areas.
A distinct epidemiological pattern of the COVID-19 epi-
demic between Hubei Province and other regions in China 
was also observed. For example, while the turning point may 
have been reached by 3 February for non-Hubei regions, Hubei 
Province reached this much later and recorded yet another peak 
on 12 February 2020 [11]. Reasons that may have led to this 
situation include the fact that Hubei Province, as the center of 
the outbreak with > 80% of reported confirmed cases, faced the 
worst impact of the epidemic and recorded higher mortality 
rates than other regions [12]. Secondary transmission in the 
region was also hard to control as more time and effort were 
required to curb the epidemic. Furthermore, prevention reac-
tion to the outbreak was slow at the outset as public health au-
thorities in Hubei Province underestimated the potential of the 
virus and did not fully react even after hundreds of cases had 
been identified. Due to this slow reaction, the opportunity for 
Figure 3. Distribution maps of cumulative coronavirus disease 2019 (COVID-19) cases in non-Hubei regions. A, Distribution of cumulative cases in non-Hubei regions by 26 
January 2020. B, Distribution of cumulative cases in non-Hubei regions by 7 February 2020. C, Distribution of cumulative cases in non-Hubei regions by 14 February 2020. D, 
Distribution of cumulative cases in non-Hubei regions by 26 February 2020.
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timely prevention of secondary transmission was missed, which 
in turn led to the global epidemic. The slow reaction time also 
seriously handicapped the health system of Hubei Province as 
> 1700 healthcare workers became infected, thereby reducing 
available medical resources for epidemic control in the region. 
Other provinces, however, learnt from Hubei’s experiences and 
reacted early by issuing Level 1 public health emergency re-
sponses. These drastic measures enabled those regions to reach 
an early turning point during the epidemic before SARS-CoV-2 
could spread further within their regions.
In terms of non–Hubei Province hotspots, Chongqing, 
Guangzhou, Shenzhen, Changsha, Nanchang, Wenzhou, 
Shanghai, Xinyang, Jining, and Beijing were found to be the 
epidemic hotspots. These cities were prone to being hotspots 
as they are either close to Hubei Province or are  in mega-
metropolises in China (especially for Chongqing, Shanghai, 
and Shenzhen), with > 10 million residents. Thus, even though 
large amounts of prevention efforts were instituted in these 
hotspots, the SARS-CoV-2 prevention and control burden is 
still extremely high in these regions. As such, even after the 
complete elimination of the infection, preventive measures will 
still be required to minimize the probability of any future epi-
demic relapse. Additionally, public health authorities in these 
regions should further investigate cases to better understand 
the facilitating factors of ongoing transmission in these areas.
This study has some limitations. First, as all of the data were 
from publicly available sources, we lacked detailed information on 
patients, which prevented us from further assessing the potential 
driving forces of the epidemic. Second, there is a time gap between 
a suspected case identification and case confirmation. Therefore, our 
analysis may not reflect the real-time situation of the epidemic; how-
ever, it still provides time-sensitive information, useful as evidence to 
aid in further response to the epidemic. Finally, due to the changes in 
diagnostic criteria for Hubei Province on 12 February 2020, the data 
reported before and 12 February 2020 onward may not be consistent 
with each other.
Figure 4. Map of hotpot analysis in non-Hubei regions of China.
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In summary, our study indicated that the turning point of the 
COVID-19 epidemic in China may have been reached in both 
Hubei and the non-Hubei regions in China. However, contin-
uous prevention efforts are still needed to achieve total elimina-
tion, and tailored strategies should be implemented in regions 
with different epidemiological patterns.
Supplementary Data
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materials are not copyedited and are the sole responsibility of the authors, so 
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